Shreedhar Vijay

Chief Commercial Officer at Adamas Pharmaceuticals Inc

Sold, on record
$67k
Dollars the filings state
Form 4 sales
3
Latest Jun 21, 2021
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
3
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Jun 21, 2021Plan not stated

    Adamas Pharmaceuticals Inc

    Sold 3.6% of their holdings

    $32k6,200 shares at $5.16

    Filed Jun 23, 2021Form 4

  2. Mar 22, 2021Plan not stated

    Adamas Pharmaceuticals Inc

    Sold 0.6% of their holdings

    $6k1,051 shares at $5.50

    Filed Mar 23, 2021Form 4

  3. Feb 1, 2021Plan not stated

    Adamas Pharmaceuticals Inc

    Sold 4.5% of their holdings

    $29k4,514 shares at $6.39

    Filed Feb 1, 2021Form 4

3 of 3

Every transaction

Every transaction on a Form 4 or Form 5 by Shreedhar Vijay
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Nov 24, 2021Nov 24, 2021Adamas Pharmaceuticals IncChief Commercial OfficerTendered186,7860SEC
Nov 24, 2021Nov 24, 2021Adamas Pharmaceuticals IncChief Commercial OfficerReturned to the companyStock Option (Right to Buy)185,0000SEC
Nov 24, 2021Nov 24, 2021Adamas Pharmaceuticals IncChief Commercial OfficerAwarded18,750186,786SEC
Jun 21, 2021Jun 23, 2021Adamas Pharmaceuticals IncChief Commercial OfficerSold6,200$5.16$32k165,735SEC
Mar 22, 2021Mar 23, 2021Adamas Pharmaceuticals IncChief Commercial OfficerSold1,051$5.50$6k169,435SEC
Mar 2, 2021Mar 3, 2021Adamas Pharmaceuticals IncChief Commercial OfficerAwarded75,000170,486SEC
Feb 1, 2021Feb 1, 2021Adamas Pharmaceuticals IncChief Commercial OfficerSold4,514$6.39$29k95,486SEC
Mar 17, 2020Mar 19, 2020Adamas Pharmaceuticals IncChief Commercial OfficerAwardedStock Option (Right to Buy)47,50047,500SEC
Mar 17, 2020Mar 19, 2020Adamas Pharmaceuticals IncChief Commercial OfficerAwarded23,75095,000SEC
Jun 7, 2019Jun 7, 2019Adamas Pharmaceuticals IncChief Commercial OfficerAwardedStock Option (Right to Buy)137,500137,500SEC
Jun 7, 2019Jun 7, 2019Adamas Pharmaceuticals IncChief Commercial OfficerAwarded68,75068,750SEC

Sales and notices (3)

Form 144 notices and Form 4 sales by Shreedhar Vijay
Source
Jun 21, 2021Jun 23, 2021Adamas Pharmaceuticals IncChief Commercial OfficerForm 4 sale6,200$32k3.6%Plan not statedSEC
Mar 22, 2021Mar 23, 2021Adamas Pharmaceuticals IncChief Commercial OfficerForm 4 sale1,051$6k0.6%Plan not statedSEC
Feb 1, 2021Feb 1, 2021Adamas Pharmaceuticals IncChief Commercial OfficerForm 4 sale4,514$29k4.5%Plan not statedSEC